BBS-Bioactive Bone Substitutes

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

MARKN.

BBS-Bioactive Bone Substitutes Plc | Company Release | April 15, 2024 at 08:00:00 EEST

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes Plc ("BBS") has received two new requests from Riverfort Global Opportunities PCC Ltd ("Riverfort") to convert convertible notes into Company shares.

  • 11 March 2024: A request to convert a proportion of EUR 54,202 of the convertible notes at a conversion price of EUR 0.44784 per share. The conversion shall be executed by transferring a total of 121,030 treasury shares to Riverfort.
  • 9 April 2024: A request to convert a proportion of EUR 80,000 of the convertible notes at a conversion price of EUR 0.40527 per share. The conversion shall be executed by transferring a total of 197,399 treasury shares to Riverfort.

In both conversions, the conversion price according to the terms and conditions is “90% of the lowest volume weighted average price of a trading day during ten trading days before the applicable subscription notice“.

After the transfers, the Company will hold a total of 606,656 treasury shares in its possession.

Datum 2024-04-15, kl 07:00
Källa MFN
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.